HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US. Read more...
Read MoreState-sponsored cyberattacks against India went up by 278% between 2021 and September 2023, a report said, adding services companies, including information technology (IT) and business process outsourcing (BPO), saw the highest share of attacks. Read more...
Read MoreIf you walked into Marie Defrancesco’s New York home, you would find an 82-year-old woman living completely alone. With no other people or pets around, you might believe that Marie has no one to interact with. Read more...
Read MoreAppdome has integrated its Cyber Defense Automation Platform with the CI/CD cloud-based service from JetBrains TeamCity allowing teams to automate the build, test and deployment of their mobile applications. JetBrains TeamCity is now part of the Appdome Dev2Cyber Agility Partner Initiative to advance the delivery of secure mobile apps globally. Read...
Read MoreLARKSPUR, Calif.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today shared new data from its Phase 1/2 clinical trial of AU-007 at the 38th Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California. The data, from Phase 1 dose escalation cohorts, continue to indicate that AU-007 is well tolerated as a monotherapy treatment or in a combination therapy regimen with low-dose, subcutaneous aldesleukin (recombinant human IL-2). The data also demonstrate early evidence of anti-tumor activity in patients with several solid tumor cancer types. Read...
Read More
